Method of treatment for reducing pain sensitization
US10940129B2 · kind B2 · utility
0Cited by
3References
15Claims
0Family size
Inventor
Key dates
| Filing date | Aug 21, 2018 |
| Grant date | Mar 9, 2021 |
| Priority date | — |
| Expiry date | Apr 11, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA23V2002/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to the use of lipophilic mercaptans for the treatment of pain sensitization. The lipophilic mercaptans disclosed can be used to decrease the formation of protein-aldehyde adducts within nociceptive nerves, thereby reducing sensitization to pain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.